{"id":"https://openalex.org/W4200522307","doi":"https://doi.org/10.1001/jamaneurol.2021.4678","title":"Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials","display_name":"Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials","alternate_titles":[],"publication_year":2021,"publication_date":"2021-12-20","ids":{"openalex":"https://openalex.org/W4200522307","doi":"https://doi.org/10.1001/jamaneurol.2021.4678","pmid":"https://pubmed.ncbi.nlm.nih.gov/34928306","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8689443"},"language":"en","primary_location":{"id":"doi:10.1001/jamaneurol.2021.4678","doi":"https://doi.org/10.1001/jamaneurol.2021.4678","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2021.4678","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2787208/jamaneurology_ashina_2021_oi_210081_1644604368.161.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4200522307"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2787208/jamaneurology_ashina_2021_oi_210081_1644604368.161.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023775224","display_name":"Messoud Ashina","orcid":"https://orcid.org/0000-0003-0951-5804","observed_orcids":["https://orcid.org/0000-0003-0951-5804"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2802086085","display_name":"Glostrup Hospital","ror":"https://ror.org/05p1frt18","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802086085","https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]},{"id":"https://openalex.org/I2802709434","display_name":"Rigshospitalet","ror":"https://ror.org/03mchdq19","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2802567020","https://openalex.org/I2802709434","https://openalex.org/I4210145385"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Messoud Ashina","raw_affiliation_strings":["Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802086085","https://openalex.org/I2802709434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004525209","display_name":"Peter James Goadsby","orcid":"https://orcid.org/0000-0003-3260-5904","observed_orcids":["https://orcid.org/0000-0003-3260-5904"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I34931013","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08","country_code":"GB","type":"government","lineage":["https://openalex.org/I34931013"]},{"id":"https://openalex.org/I87048295","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I87048295"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J. Goadsby","raw_affiliation_strings":["Department of Neurology, UCLA (University of California, Los Angeles)","National Institute for Health Research\u2013Wellcome Trust King\u2019s Clinical Research Facility, King\u2019s College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, UCLA (University of California, Los Angeles)","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"National Institute for Health Research\u2013Wellcome Trust King\u2019s Clinical Research Facility, King\u2019s College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753","https://openalex.org/I34931013","https://openalex.org/I87048295"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057290642","display_name":"David W. Dodick","orcid":"https://orcid.org/0000-0002-9486-6790","observed_orcids":["https://orcid.org/0000-0002-9486-6790"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David W. Dodick","raw_affiliation_strings":["Department of Neurology, Mayo Clinic, Scottsdale, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Mayo Clinic, Scottsdale, Arizona","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064341657","display_name":"Stewart J. Tepper","orcid":"https://orcid.org/0000-0002-9879-6638","observed_orcids":["https://orcid.org/0000-0002-9879-6638"]},"institutions":[{"id":"https://openalex.org/I107672454","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22","country_code":"US","type":"education","lineage":["https://openalex.org/I107672454"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stewart J. Tepper","raw_affiliation_strings":["Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, New Hampshire"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisel School of Medicine at Dartmouth, Dartmouth College, Hanover, New Hampshire","institution_ids":["https://openalex.org/I107672454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089710591","display_name":"Fei Xue","orcid":"https://orcid.org/0000-0001-7047-8497","observed_orcids":["https://orcid.org/0000-0001-7047-8497"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fei Xue","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100401224","display_name":"Feng Zhang","orcid":"https://orcid.org/0000-0001-9401-4339","observed_orcids":["https://orcid.org/0000-0001-9401-4339","https://orcid.org/0009-0000-5309-8476"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Feng Zhang","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Francis Brennan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francis Brennan","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026269499","display_name":"Gabriel Paiva da Silva Lima","orcid":"https://orcid.org/0000-0001-8073-719X","observed_orcids":["https://orcid.org/0000-0001-8073-719X"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriel Paiva da Silva Lima","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, California","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5023775224"],"corresponding_institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2802086085","https://openalex.org/I2802709434"],"apc_list":null,"apc_paid":null,"fwci":3.6049,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.94584991,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"79","issue":"2","first_page":"159","last_page":"159"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11579","display_name":"Cardiovascular and Diving-Related Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erenumab","display_name":"erenumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/migraine-with-aura","display_name":"migraine with aura","score":0.9950000047683716},{"id":"https://openalex.org/keywords/migraine-without-aura","display_name":"migraine without aura","score":0.9350000023841858},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/cgrp-receptor-antibody","display_name":"CGRP receptor antibody","score":0.6899999976158142},{"id":"https://openalex.org/keywords/episodic-migraine","display_name":"episodic migraine","score":0.7749999761581421},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monthly-migraine-days","display_name":"monthly migraine days","score":0.8610000014305115},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8360000252723694},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5529999732971191},{"id":"https://openalex.org/keywords/migraine-disability","display_name":"migraine disability","score":0.38199999928474426},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.47099998593330383},{"id":"https://openalex.org/keywords/extension-phase","display_name":"extension phase","score":0.3089999854564667},{"id":"https://openalex.org/keywords/subcutaneous-injection","display_name":"subcutaneous injection","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2777350023","wikidata":"https://www.wikidata.org/wiki/Q1154226","display_name":"Aura","level":3,"score":0.8907723426818848},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7324825525283813},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6089790463447571},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3801574110984802},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25676408410072327}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020325","descriptor_name":"Migraine with Aura","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020326","descriptor_name":"Migraine without Aura","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1001/jamaneurol.2021.4678","doi":"https://doi.org/10.1001/jamaneurol.2021.4678","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2021.4678","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2787208/jamaneurology_ashina_2021_oi_210081_1644604368.161.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8689443","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8689443/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurol","raw_type":"Text"},{"id":"pmid:34928306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34928306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA neurology","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:openaire/bfefb5b0-0124-404a-9722-231157003acf","doi":null,"is_oa":true,"landing_page_url":"https://kclpure.kcl.ac.uk/portal/en/publications/bfefb5b0-0124-404a-9722-231157003acf","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ashina, M, Goadsby, P J, Dodick, D W, Tepper, S J, Xue, F, Zhang, F, Brennan, F & Paiva Da Silva Lima, G 2021, 'Assessment of Erenumab Safety and Efficacy in Patients with Migraine with and without Aura : A Secondary Analysis of Randomized Clinical Trials', JAMA Neurology. https://doi.org/10.1001/jamaneurol.2021.4678","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire/ccafd7f9-31d7-4230-bad5-aa71d522cbcb","doi":null,"is_oa":true,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/ccafd7f9-31d7-4230-bad5-aa71d522cbcb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ashina, M, Goadsby, P J, Dodick, D W, Tepper, S J, Xue, F, Zhang, F, Brennan, F & Paiva Da Silva Lima, G 2022, 'Assessment of Erenumab Safety and Efficacy in Patients with Migraine with and Without Aura : A Secondary Analysis of Randomized Clinical Trials', JAMA Neurology, vol. 79, no. 2, pp. 159-168. https://doi.org/10.1001/jamaneurol.2021.4678","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1001/jamaneurol.2021.4678","doi":"https://doi.org/10.1001/jamaneurol.2021.4678","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaneurol.2021.4678","pdf_url":"https://jamanetwork.com/journals/jamaneurology/articlepdf/2787208/jamaneurology_ashina_2021_oi_210081_1644604368.161.pdf","source":{"id":"https://openalex.org/S164389565","display_name":"JAMA Neurology","issn_l":"2168-6149","issn":["2168-6149","2168-6157"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1254462217","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0616-10031","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G2824360226","display_name":"Synaptopathies: genetics, biophysics and circuit mechanisms of paroxysmal neurological disorders.","funder_award_id":"104033/Z/14/Z","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G6291771466","display_name":"NIHR Senior Investigator Award","funder_award_id":"NIHR201369","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308927","display_name":"Patient-Centered Outcomes Research Institute","ror":"https://ror.org/014q65q44"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320315053","display_name":"Acorda Therapeutics","ror":"https://ror.org/01788sq40"},{"id":"https://openalex.org/F4320315343","display_name":"American Headache Society","ror":"https://ror.org/00vq6eh39"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320273","display_name":"University of Cambridge","ror":"https://ror.org/013meh722"},{"id":"https://openalex.org/F4320320290","display_name":"University of Oxford","ror":"https://ror.org/052gg0110"},{"id":"https://openalex.org/F4320321999","display_name":"Lundbeckfonden","ror":"https://ror.org/03hz8wd80"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200522307.pdf","grobid_xml":"https://content.openalex.org/works/W4200522307.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W2001650386","https://openalex.org/W2011259393","https://openalex.org/W2038218097","https://openalex.org/W2114480099","https://openalex.org/W2115558652","https://openalex.org/W2119228931","https://openalex.org/W2129181629","https://openalex.org/W2268603990","https://openalex.org/W2283260670","https://openalex.org/W2608751463","https://openalex.org/W2770965214","https://openalex.org/W2792811290","https://openalex.org/W2794583203","https://openalex.org/W2971523011","https://openalex.org/W3011773752","https://openalex.org/W3013178006","https://openalex.org/W3033681381","https://openalex.org/W3150487324","https://openalex.org/W4229691578","https://openalex.org/W4254908862","https://openalex.org/W4292528167"],"related_works":["https://openalex.org/W2806335825","https://openalex.org/W2805440854","https://openalex.org/W2997725658","https://openalex.org/W4308954661","https://openalex.org/W4293565703","https://openalex.org/W2980838981","https://openalex.org/W4293230616","https://openalex.org/W3176839476","https://openalex.org/W3199392638","https://openalex.org/W2917033428"],"abstract_inverted_index":{"Importance:":[0],"Migraine":[1],"with":[2,14,16,47,49,96,269,292,340,344,347,409,438,443,445],"aura":[3,17,275,397],"may":[4],"respond":[5],"differently":[6],"to":[7,93,105,198,316,330,364,378,402],"therapies":[8],"than":[9,264],"migraine":[10,15,28,48,98,101,173,294,346,433,444],"without":[11,271,447],"aura.":[12,50,202,451],"Individuals":[13],"have":[18],"an":[19],"elevated":[20],"vascular":[21],"risk,":[22],"necessitating":[23],"a":[24,236,272,296,348,448],"safety":[25,41,388,458],"assessment":[26],"of":[27,43,116,189,193,201,222,240,274,298,350,396,404,413,422,426,450,459],"preventive":[29],"treatments":[30],"in":[31,45,70,73,133,211,261,267,303,318,332,366,380,441,462],"this":[32,423,463],"patient":[33,187,464],"subgroup.":[34],"Objective:":[35],"To":[36],"assess":[37],"the":[38,134,205,212,262,277,287,352,455],"efficacy":[39,456],"and":[40,53,78,84,102,138,144,164,176,229,244,256,270,281,295,325,373,399,419,435,446,457,474],"profiles":[42,389],"erenumab":[44,108,117,263,439,461],"patients":[46,194,207,268,291,343,442],"Design,":[51],"Setting,":[52],"Participants:":[54],"This":[55],"post":[56],"hoc":[57],"secondary":[58,424],"analysis":[59,425],"evaluated":[60],"4":[61,213,427],"double-blind,":[62],"placebo-controlled":[63],"randomized":[64,104,210,428],"clinical":[65,429],"trials":[66,430],"that":[67,403],"were":[68,89,103,195,209,245,259,284,311,359,390,400],"conducted":[69],"treatment":[71,136,279,358,393,440],"centers":[72],"North":[74],"America,":[75],"Europe,":[76],"Russia,":[77],"Turkey":[79],"between":[80],"August":[81],"6,":[82],"2013,":[83],"November":[85],"12,":[86],"2019.":[87],"Participants":[88],"adults":[90],"aged":[91],"18":[92],"65":[94],"years":[95,243],"episodic":[97,293],"or":[99,109,113,120,126,140,148,219,226],"chronic":[100,345],"receive":[106],"either":[107],"placebo.":[110,233,341],"Interventions:":[111],"One":[112],"more":[114,220],"dose":[115,221],"(70":[118],"mg":[119,122,147,225],"140":[121,149,227,337,385],"once":[123,153],"per":[124,154],"month)":[125],"placebo":[127,265,357,405],"was":[128,151],"administered":[129,152],"by":[130,156],"subcutaneous":[131,157],"injection":[132,158],"double-blind":[135,278],"phase":[137],"open-label":[139],"dose-blinded":[141],"active":[142],"treatment,":[143],"erenumab,":[145,223,322,336,370,384],"70":[146,224,323,371],"mg,":[150,228,324,338,372],"month":[155],"during":[159,276],"extension":[160,288],"phases.":[161,289],"Main":[162],"Outcomes":[163],"Measures:":[165],"Efficacy":[166],"assessments":[167],"included":[168,186],"change":[169,304],"from":[170,253,305,356],"baseline":[171,254,306],"monthly":[172,177],"days":[174,258,437],"(MMDs)":[175],"acute":[178],"migraine-specific":[179],"medication":[180],"(AMSM)":[181],"days.":[182],"Safety":[183],"end":[184],"points":[185],"incidences":[188],"adverse":[190,414],"events.":[191],"Subgroups":[192],"categorized":[196],"according":[197],"their":[199],"history":[200,273,297,349,398,449],"Results:":[203],"Of":[204],"2682":[206],"who":[208,320,334,368,382],"trials,":[214],"1400":[215],"(52.2%)":[216],"received":[217,232,321,335,369,383],"1":[218],"1043":[230],"(38.9%)":[231],"Patients":[234],"had":[235],"mean":[237,301,354],"(SD)":[238],"age":[239],"41.7":[241],"(11.2)":[242],"predominantly":[246],"women":[247],"(n":[248],"=":[249],"2055":[250],"[84.1%]).":[251],"Reductions":[252],"MMDs":[255,307],"AMSM":[257,436],"greater":[260],"groups":[266,394],"phase,":[280],"these":[282],"reductions":[283],"maintained":[285],"throughout":[286],"In":[290,342],"aura,":[299,351],"least-squares":[300,353],"differences":[302,355],"at":[308],"week":[309],"12":[310,407],"-1.1":[312],"(95%":[313,327,361,375],"CI,":[314,328,362,376],"-1.7":[315],"-0.6)":[317],"those":[319,333,367,381],"-0.9":[326],"-1.6":[329],"-0.2)":[331],"compared":[339],"-2.1":[360],"-3.8":[363],"-0.5)":[365],"-3.1":[374],"-4.8":[377],"-1.4)":[379],"mg.":[386],"Overall":[387],"similar":[391],"across":[392],"regardless":[395],"comparable":[401],"over":[406,416],"weeks,":[408],"no":[410],"increased":[411],"emergence":[412],"events":[415],"time.":[417],"Conclusions":[418],"Relevance:":[420],"Results":[421],"showed":[431],"reduced":[432],"frequency":[434],"The":[452],"findings":[453],"support":[454],"using":[460],"population.":[465],"Trial":[466],"Registration:":[467],"ClinicalTrials.gov":[468],"Identifiers:":[469],"NCT01952574,":[470],"NCT02456740,":[471],"NCT02483585,":[472],"NTCT02066415,":[473],"NCT02174861.":[475]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4200522307","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-12-31T00:00:00"}
